Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Amphetamine Sulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,783Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kye Pharmaceuticals wins approval for DYANAVEL® XR in ADHD
    Kye Pharmaceuticals wins approval for DYANAVEL® XR in ADHD

    06 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kye-pharmaceuticals-announces-the-approval-of-dyanavel-xr-amphetamine-extended-release-tablets-and-oral-suspension-for-the-treatment-of-adults-and-children-with-adhd-302519894.html

    PR NEWSWIRE
    06 Aug 2025
    Share Share
    Glenmark to launch generic version of Adderall Tablets
    Glenmark to launch generic version of Adderall Tablets

    17 Apr 2025

    // EXPRESSPHARM

    https://www.expresspharma.in/glenmark-to-launch-generic-version-of-adderall-tablets-in-the-us-market-by-may-2025/

    EXPRESSPHARM
    17 Apr 2025
    Share Share
    FDA Confirms Para IV Patent Litigation for Dyanavel XR Tablets
    FDA Confirms Para IV Patent Litigation for Dyanavel XR Tablets

    21 Mar 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-dyanavel-xr-tablets-47566.pdf

    FDA
    21 Mar 2025
    Share Share
    Enforcement Report - Week of November 27, 2024
    Enforcement Report - Week of November 27, 2024

    27 Nov 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-27-2024-27890.pdf

    FDA
    27 Nov 2024
    Share Share
    Lupin receives FDA approval for generic version of Adderall XR
    Lupin receives FDA approval for generic version of Adderall XR

    21 Nov 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/lupin-receives-fda-approval-for-generic-version-of-adderall-xr/

    EXPRESSPHARMA
    21 Nov 2024
    Share Share
    US charges executives at ADHD startup in Adderall fraud
    US charges executives at ADHD startup in Adderall fraud

    13 Jun 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-charges-executives-adhd-startup-adderall-fraud-2024-06-13/

    REUTERS
    13 Jun 2024
    Share Share